☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
summit therapeutics
Summit Therapeutics Partners with Pfizer to Assess Ivonescimab in Combination with Pfizer’s ADCs for Various Solid Tumor Settings
February 25, 2025
Summit Therapeutics Reports Results of Ridinilazole in P-III (Ri-CoDIFy) Study for the Treatment of Clostridioides Difficile Infec...
December 20, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.